Table 1.
Baseline characteristics
| Current Study N=10,886 | Not in Current Study N=6,916 | Overall Study N=17,802 | |
|---|---|---|---|
|
| |||
| Characteristic | Median (25th – 75th %ile) or N (%) | Median (25th – 75th %ile) or N (%) | Median (25th – 75th %ile) or N (%) |
| Age | 66 (60 – 71) | 66 (61 – 71) | 66 (60 – 71) |
| Women | 3,917 (36.0%) | 2884 (41.7%) | 6801 (38.2%) |
| Rosuvastatin | 5,367 (49.3%) | 3,534 (51.1%) | 8901 (50.0%) |
| Race/ethnicity | |||
| White | 8,982 (82.5%) | 3,701 (53.5%) | 12,683 (71.3%) |
| Black | 775 (7.1%) | 1,449 (21.0%) | 2,224 (12.5%) |
| Asian | 151 (1.4%) | 132 (1.9%) | 283 (1.6%) |
| Hispanic | 895 (8.2%) | 1,366 (19.8%) | 2,261 (12.7%) |
| Other/unknown | 83 (0.8%) | 266 (3.9%) | 349 (2.0%) |
| Body-mass index, kg/m2 | 28.4 (25.5 – 32.0) | 28.2 (25.0 – 32.0) | 28.4 (25.3 – 32.0) |
| Systolic blood pressure, mm Hg | 134 (124 – 146) | 134 (124 – 144) | 134 (124 – 145) |
| Diastolic blood pressure, mm Hg | 80 (75 – 86) | 80 (75 – 88) | 80 (75 – 87) |
| Current smoker | 1620 (14.9%) | 1,200 (17.4%) | 2,820 (15.9%) |
| Family history of premature coronary disease | 1,387 (12.8%) | 658 (9.6%) | 2,045 (11.5%) |
| Glucose, mg/dL | 95 (88 –102) | 93 (86 – 101) | 94 (88 – 102) |
| High-sensitivity C-reactive protein, mg/L | 4.1 (2.8 – 6.8) | 4.6 (2.9 – 7.7) | 4.3 (2.9 – 7.1) |
| LDL cholesterol, mg/dL | 109 (95 – 119) | 107 (92 – 118) | 108 (94 – 119) |
| Total cholesterol, mg/dL | 186 (171 – 200) | 184 (166 – 199) | 185 (169 – 200) |
| Triglycerides, mg/dL | 116 (84 – 166) | 121 (88 – 174) | 118 (85 – 169) |
| HDL cholesterol, mg/dL | 49 (41 – 60) | 48 (39 – 58) | 49 (40 – 60) |
| Apolipoprotein A-I, mg/dL | 164 (146 – 185) | 159 (141 – 182) | 162 (144 – 184) |
| HDL size, nm | 9.0 (8.6–9.4) | --- | --- |
| HDL particles, μmol/L | 32.2 (28.3–36.5) | --- | --- |
Percentages may not add up due to rounding off